Park Place Capital Corp Sells 481 Shares of Humana Inc. (NYSE:HUM)

Park Place Capital Corp trimmed its stake in Humana Inc. (NYSE:HUM) by 48.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 507 shares of the insurance provider’s stock after selling 481 shares during the period. Park Place Capital Corp’s holdings in Humana were worth $129,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. FNY Investment Advisers LLC raised its holdings in Humana by 6,647.5% in the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock worth $6,916,000 after purchasing an additional 26,856 shares in the last quarter. PDT Partners LLC lifted its position in Humana by 190.0% during the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after acquiring an additional 2,660 shares during the last quarter. Ontario Teachers Pension Plan Board lifted its position in Humana by 6.5% during the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after acquiring an additional 71,910 shares during the last quarter. Swedbank AB boosted its stake in Humana by 3.0% in the third quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock valued at $33,567,000 after acquiring an additional 3,085 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB purchased a new position in Humana in the third quarter worth $948,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Trading Up 0.1 %

Humana stock opened at $284.93 on Thursday. The firm has a market cap of $34.31 billion, a PE ratio of 25.24, a P/E/G ratio of 2.15 and a beta of 0.55. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $411.80. The stock’s 50 day simple moving average is $273.91 and its two-hundred day simple moving average is $306.03. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The firm had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Analysts anticipate that Humana Inc. will post 16.11 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently weighed in on HUM. Deutsche Bank Aktiengesellschaft lowered their price objective on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. Stephens reissued an “equal weight” rating and issued a $250.00 price target on shares of Humana in a report on Wednesday, October 9th. Bank of America upgraded shares of Humana from an “underperform” rating to a “neutral” rating and upped their price objective for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. TD Cowen increased their price objective on shares of Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Finally, Leerink Partnrs downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Twenty research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $302.80.

Insiders Place Their Bets

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.32% of the stock is currently owned by company insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.